NCT04001452 is a clinical trial in Coronary Artery Disease, sponsored by Medical University of Graz.

Who is sponsoring NCT04001452?

NCT04001452 is sponsored by Medical University of Graz.

What condition does NCT04001452 study?

NCT04001452 studies Coronary Artery Disease.

Is NCT04001452 still recruiting?

NCT04001452 is currently status unknown. Last updated 28 June 2019.

Last reviewed 2019-06-28 · How we verify

NCT04001452

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

2nd International Survey on Interventional Strategies

Status unknown Last updated 28 June 2019

What this trial tests

trial in Coronary Artery Disease in 500 participants. Status unknown.

Timeline

1 July 2019

Primary endpoint
31 December 2019

31 January 2020

Quick facts

Lead sponsor	Medical University of Graz
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	500
Start date	1 July 2019
Primary completion	31 December 2019
Estimated completion	31 January 2020

Conditions studied

Coronary Artery Disease — all drugs for Coronary Artery Disease →

Sponsor

Medical University of Graz

Who can join

Eligibility, any sex, with Coronary Artery Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study aims to evaluate the decision-making pathways of interventional cardiologists, when assessing patients, presented with stable coronary artery disease.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Revascularization decisions in patients with chronic coronary syndromes: Results of the second International Survey on Interventional Strategy (ISIS-2).
G Toth G, Johnson NP, Wijns W, Toth B, et al · · 2021 · cited 20× · PMID 33971185 · DOI 10.1016/j.ijcard.2021.05.005

Verify or expand the search:

Other recruiting trials for Coronary Artery Disease

Currently open trials in the same condition.

NCT07399002 — LONG NAGOMI™ PMCF STUDY · recruiting
NCT07420582 — Antegrade Autologous Blood Reinfusion After CPB · recruiting
NCT07493603 — A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease · Phase 1, PHASE2 · recruiting
NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting

Other Medical University of Graz trials

Trials by the same sponsor.

NCT07498244 — Collagen Fingerprinting for Stratification of Pulmonary Hypertension (PH) Patients · recruiting
NCT07492823 — Clinical Applicability of Liquid Biopsy in Chondrosarcoma · not yet recruiting
NCT07297615 — 3D Liver Volumetry · NA · not yet recruiting
NCT07588282 — The Effect of Psychoeducational Diagnosis Communication on Perception of Illness, Satisfaction, and Behavioral Intention · NA · recruiting
NCT07376096 — Liquid Biopsy in Germ Cell Tumors · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04001452 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Medical University of Graz
Last refreshed: 28 June 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04001452.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing